Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | TYR | P14679 | 1/20 | 1.00 |
| ▸ | DAO | P14920 | 1/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 4/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Hydroxycoumarin SCHEMBL29397603 | 1.00 | HPGD (1.00) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL28258929 | 0.98 | HPGD (0.96) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL28145356 | 0.94 | HPGD (0.89) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL31476361 | 0.94 | HPGD (0.89) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL16011243 | 0.93 | HPGD (0.86) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL28805372 | 0.93 | HPGD (0.86) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL3837239 | 0.93 | HPGD (0.86) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL28186257 | 0.93 | HPGD (0.86) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL27836527 | 0.93 | HPGD (0.86) | HPGDTYRDAOAKR1B1LMNA | |
| 3-Hydroxycoumarin SCHEMBL6401867 | 0.91 | HPGD (0.83) | HPGDTYRDAOAKR1B1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13369 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107279-A1 | METHOD FOR ASSESSING VIABILITY OF MICROBIAL STRAINS | Kanvas Biosciences, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026102006-A1 | METHOD FOR IDENTIFYING MICROBIAL STRAINS | Kanvas Biosciences, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026102332-A1 | NERVE AND TUMOR HOMING AGENTS AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4676949-A2 | ANTIGEN BINDING MOLECULES AND METHODS OF USE | Kite Pharma, Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260010026-A1 | ENGINEERED LIQUID CRYSTAL SHUTTER AS A DYNAMIC LONG-PASS OPTICAL FILTER | BLAZE BIOSCIENCE INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4661841-A1 | DEGARELIX ORGANIC SOLVENT FORMULATIONS | Tolmar International Limited (IE) | 2025-12-17 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4634235-A1 | CD70 ANTI-IDIOTYPE ANTIBODIES | Allogene Therapeutics, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| US-4620850-A | HYDROXYBENZOLFURANONE | WELLA AKTIENGESELLSCHAFT (DE) | 1986-11-04 | — | — | US | claimed |
| US-4616033-A | 7 hydroxy-coumarin as a treatment for high protein oedemas | LAMORNA INVESTMENTS PROPRIETARY LTD. (AU) | 1986-10-07 | — | — | US | claimed |
| EP-0172893-A1 | TREATMENT OF HIGH PROTEIN OEDEMAS IN ANIMALS | LAMORNA INVESTMENTS PROPRIETARY LIMITED (AU) | 1986-03-05 | — | — | EP | claimed |
| WO-1985003864-A1 | TREATMENT OF HIGH PROTEIN OEDEMAS BY DIRECT APPLICATION OF BENZO-PYRONES | CASLEY SMITH JOHN ROYLE (AU) | 1985-09-12 | — | — | WO | claimed |
| WO-1985003865-A1 | TREATMENT OF HIGH PROTEIN OEDEMAS IN ANIMALS | CASLEY SMITH JOHN ROYLE | 1985-09-12 | — | — | WO | claimed |
| EP-0111746-A2 | Sulfonic-acid esters of hydroxycoumarines, their preparation and medicines containing them | BASF Aktiengesellschaft (DE) | 1984-06-27 | — | — | EP | claimed |
| EP-0026473-B1 | OXIDATIVE HAIR-DYEING COMPOSITION | Wella Aktiengesellschaft (DE) | 1983-05-25 | — | — | EP | claimed |
| US-4308348-A | SALMONELLA, SERRATIA, PROTEUS, PROVIDENCIA | LABORATOIRE DE RECHERCHE API (FR) | 1981-12-29 | — | — | US | claimed |
| EP-0026473-A1 | Oxidative hair-dyeing composition | Wella Aktiengesellschaft (DE) | 1981-04-08 | — | — | EP | claimed |
| WO-1981000810-A1 | COMPOSITION ALLOWING THE COLORATION OF HAIR BY OXIDATION | WELLA AG (DE) | 1981-04-02 | — | — | WO | claimed |